Valuation : Chrome Holding Co.

Market Cap 96.6M 83.23M 78.81M 71.43M 134M 9.23B 135M 936M 360M 4.7B 363M 355M 14.84B P/E 2024
-0.38x
P/E 2025 -0.07x
Enterprise Value 65.86M 56.75M 53.73M 48.7M 91.37M 6.29B 91.83M 638M 245M 3.2B 247M 242M 10.12B EV / Sales 2024
0.53x
EV / Sales 2025 -0.06x
Free-Float
68.5%
Yield 2024 *
-
Yield 2025 -
1 year 2.41
Extreme 2.41
4.05
3 years 0.47
Extreme 0.4701
22.6
5 years 0.47
Extreme 0.4701
273.6
10 years 0.47
Extreme 0.4701
363.2
Manager TitleAgeSince
Chief Executive Officer 63 2025-03-22
Chief Tech/Sci/R&D Officer - 2024-08-31
Chief Tech/Sci/R&D Officer 48 2006-12-31
Director TitleAgeSince
Chairman 52 2005-12-31
Director/Board Member 57 2024-10-27
Director/Board Member 61 2024-10-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/25 Tax

Chief Executive Officer

5,232 0.0206%
6/9/25 Conversion

Founder

4,931,692 25.0063%
5/20/25 Tax

Chief Executive Officer

5,073 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-.--%-10.94%-84.65% 96.4M
+0.86%+0.23%+89.25%+502.55% 47.39B
+1.49%-4.70%+11.38%+54.28% 25.27B
-1.91%-2.76%-15.37%-38.61% 6.73B
+1.63%+2.41%+2.39%+156.68% 5.94B
-0.40%+1.68%+16.26%+71.90% 3.34B
+1.55%-0.84%-32.27%+1,687.53% 2.54B
+12.74%+4.41%+35.00%+45.74% 2.24B
-1.65%-0.35%+107.67%+24.69% 2.23B
-0.73%-2.96%-19.36%-56.60% 1.76B
Average +1.08%+0.60%+18.40%+236.35% 9.75B
Weighted average by Cap. +1.04%-1.04%+48.01%+312.05%

Financials

2024 2025
Net sales 220M 189M 179M 162M 305M 20.98B 306M 2.13B 818M 10.68B 825M 807M 33.73B 190M 164M 155M 140M 263M 18.14B 265M 1.84B 708M 9.23B 713M 698M 29.16B
Net income -667M -574M -544M -493M -925M -63.69B -930M -6.46B -2.48B -32.4B -2.5B -2.45B -102B -281M -242M -229M -208M -390M -26.83B -392M -2.72B -1.05B -13.65B -1.05B -1.03B -43.14B
Net Debt -140M -121M -114M -104M -194M -13.37B -195M -1.36B -522M -6.8B -526M -514M -21.5B -30.74M -26.48M -25.07M -22.73M -42.64M -2.94B -42.85M -298M -115M -1.49B -115M -113M -4.72B
Logo Chrome Holding Co.
Chrome Holding Co., formerly 23andMe Holding Co., is a genetics-led consumer healthcare company. As a part of TTAM Research Institute (TTAM), the Company operates and provides customers with personalized deoxyribonucleic acid (DNA) testing and research services.
Employees
261
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!